Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

RaQualia Pharma Inc Extends Co-development Period with Eli Lilly And Co


Friday, 19 Jul 2013 02:40am EDT 

RaQualia Pharma Inc announced that it has decided to extend the co-development period of analgesic with Eli Lilly And Co, based on the agreement signed on December 2010 between the two companies. 

Company Quote

70.37
-0.75 -1.05%
3 Mar 2015